Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2019 Publisher: Amdipharm UK Limited, Capital House, 85 King William Street, London EC4N 7BL, UK
Rhotard Morphine SR 30 mg Tablets.
Morphgesic SR 30mg Tablets.
| Pharmaceutical Form |
|---|
|
Controlled release tablets. Each 30 mg tablet is a violet coloured biconvex round film coated tablet. |
Rhotard Morphine SR 30 mg Tablets/Morphgesic SR 30 mg Tablets.
Each tablet contains 30 mg of morphine sulphate.
Excipients with known effect:
Lactose (63.000 mg per tablet).
FD&C Yellow #6/Sunset Yellow FCF Lake (E110).
For the full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Morphine |
Morphine is a narcotic analgesic obtained from opium. Morphine acts as an agonist at opiate receptors in the CNS particularly Mu and to a lesser extent Kappa receptors. Mu receptors are thought to mediate supraspinal analgesia, respiratory depression and euphoria, and Kappa receptors, spinal analgesia, miosis and sedation. |
| List of Excipients |
|---|
|
Lactose Rhotard Morphine SR/Morphgesic SR 30 mg tablets contain the colourants listed below: Erythrosine lake (E127) |
Each pack contains either 10 or 60 tablets in PVC blister packs with aluminium foil lidding.
Amdipharm UK Limited, Capital House, 85 King William Street, London EC4N 7BL, UK
PL 20075/0232
Date of first authorisation: 28 June 2002
| Drug | Countries | |
|---|---|---|
| MORPHGESIC | Cyprus, United Kingdom |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
